Records containing: Nonalcoholic Steatohepatitis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-11-24CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Recombinant Human Leptin (METRELEPTIN) in Various Forms of Partial Lipodystrophy
-
CLINICAL_TRIALS study record update · 2020-09-28Phase 2 Study to Evaluate Non-Invasive Imaging Methods in Efficacy Assessment of GR-MD-02 for the Treatment of Liver Fibrosis in Patients With NASH With Advanced Fibrosis
-
CLINICAL_TRIALS study record update · 2020-09-04RiFL: Rifaximin in Fatty Liver Disease. Does Modulation of Gut Microbiota Reduce Hepatic Inflammation in Non-Alcoholic Steatohepatitis (NASH)?
-
CLINICAL_TRIALS study record update · 2020-07-21Colesevelam Versus Placebo in the Treatment of Nonalcoholic Steatohepatitis
-
CLINICAL_TRIALS study record update · 2020-07-08Non Alcoholic Fatty Liver Disease and Coronary Heart Disease in Type 2 Diabetes Patients
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-06-29A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis
-
CLINICAL_TRIALS study record update · 2020-05-07A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Selonsertib in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
-
CLINICAL_TRIALS study record update · 2020-03-19An Open-Label, Single-Dose, Fixed-Sequence Crossover Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986036 Administered to the Abdomen and Upper Arm in Healthy Participants
-
CLINICAL_TRIALS study record update · 2020-03-10A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING, PARALLEL GROUP STUDY TO EVALUATE SAFETY, TOLERABILITY, AND PHARMACODYNAMICS OF PF-05221304 ADMINISTERED DAILY FOR 16-WEEKS TO ADULT SUBJECTS WITH NONALCOHOLIC FATTY LIVER DISEASE
-
CLINICAL_TRIALS study record update · 2020-01-28A Pilot Evaluation of the Effect of the Erchonia Verjú™ and EVRL Lasers on Reducing Aminoalanine Transaminase (ALT) in Individuals With Nonalcoholic Steatohepatitis (NASH)
-
CLINICAL_TRIALS study record update · 2019-10-21A Double-Blind Randomized Placebo-Controlled Single and Multiple Ascending Doses Study of the Safety and Tolerability, Pharmacokinetics (Including Bioavailability Comparison and Food Effect) and Pharmacodynamics of Oral BMS-986251 Administration in Healthy Subjects, With Efficacy Assessment of Multiple Doses in Patients With Moderate-to-Severe Psoriasis
-
CLINICAL_TRIALS study record update · 2019-10-08A Phase 1, Open-Label, Parallel-Group, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-986036 in Participants With Varying Degrees of Renal Function
-
CLINICAL_TRIALS study record update · 2019-07-11A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SGM-1019 Administered for 12 Weeks in Subjects With F1-F3 Nonalcoholic Steatohepatitis (NASH)
-
CLINICAL_TRIALS study record update · 2019-05-16Development of Non-invasive Magnetic Resonance Imaging Diagnostic Method for Nonalcoholic Steatohepatitis(NASH)
-
CLINICAL_TRIALS study record update · 2019-05-10CENTAUR: Efficacy and Safety Study of Cenicriviroc for the Treatment of Nonalcoholic Steatohepatitis (NASH) in Adult Subjects With Liver Fibrosis
-
CLINICAL_TRIALS study record update · 2019-03-04Feasibility of Vigorous-Intensity Interval Training in Adults With Nonalcoholic Steatohepatitis
-
CLINICAL_TRIALS study record update · 2019-01-07A Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Phase II Trial of JKB-121 for the Treatment of Nonalcoholic Steatohepatitis (NASH)
-
CLINICAL_TRIALS study record update · 2018-10-31Non-invasive Evaluation of Liver Fibrosis, Steatosis, and Nonalcoholic Steatohepatitis in Biopsy-Proven NAFLD Patients
-
CLINICAL_TRIALS study record update · 2018-09-11NAFLD in T2DM: Prevalence in Hispanics and Role of Treatment
-
CLINICAL_TRIALS study record update · 2018-08-21Nonalcoholic Fatty Liver Disease and Associated Liver Fibrosis in Peri-menopausal Women
-
CLINICAL_TRIALS study record update · 2018-06-04A Phase 2, Randomized, Double Blind, Placebo Controlled Clinical Study Investigating the Effects of Obeticholic Acid and Atorvastatin Treatment on Lipoprotein Metabolism in Subjects With Nonalcoholic Steatohepatitis
-
CLINICAL_TRIALS study record update · 2018-02-06Prospective Cohort Assessing the Prevalence and Progress of Non-alcoholic Fatty Liver Disease (NAFLD)/Non-alcoholic Steatohepatitis (NASH) in Chinese
-
CLINICAL_TRIALS study record update · 2017-10-10Effect of Dietary and Life Style Modification on Post Liver Transplant Obesity
-
CLINICAL_TRIALS study record update · 2017-10-06Effect of Probiotics in the Treatment of Nonalcoholic Fatty Liver Disease
-
CLINICAL_TRIALS study record update · 2017-06-14Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy